Angiogenesis inhibitors in the treatment of cancer

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.10, 2005-08, pp. : 1701-1711

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis inhibitors in the treatment of prostate cancer

By Kluetz Paul G Figg William D Dahut William L

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 233-247

Informa Healthcare

Access to resources Recommend Favorite

Targeting angiogenesis for the treatment of prostate cancer

By Antonarakis Emmanuel S Carducci Michael A

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 4, 2012-04 ,pp. : 365-376

Informa Healthcare

Access to resources Recommend Favorite

Update on bevacizumab and other angiogenesis inhibitors for brain cancer

By Rinne Mikael L Lee Eudocia Q Nayak Lakshmi Norden Andrew D Beroukhim Rameen Wen Patrick Y Reardon David A

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 137-153

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis Inhibitors: New Agents in Cancer Therapy

By Ryan C.J.

Drugs & Aging, Vol. 17, Iss. 4, 2000-10 ,pp. : 249-255

Adis International

Access to resources Recommend Favorite

Targeted Therapy of Ovarian Cancer with Angiogenesis Inhibitors

Current Drug Targets, Vol. 18, Iss. 10, 2017-07 ,pp. : 1171-1178

Bentham Science Publishers

Access to resources Recommend Favorite